Market Overview

Benzinga's Top Downgrades

Share:
Benzinga's Top Downgrades
Related JNJ
Write A Prescription For More Pharma M&A With This ETF
Goldman Sachs Talks Pfizer's Acquisition Deal Of Medivation
Tight Trading on Thursday with Stocks Ending Lower (GuruFocus)
Related JCP
Pfizer, Target, JC Penney: Fast Money Picks For August 23
Jefferies Sees Ample Opportunity For Margin Recovery At JCPenney
Sears Holdings Reports Steep Loss, Takes Loan From Lampert in Q— (GuruFocus)

Analysts at Jefferies downgraded Johnson & Johnson (NYSE: JNJ) from “buy” to “hold.” Johnson & Johnson's shares closed at $69.87 on Friday. Johnson & Johnson's trailing-twelve-month profit margin is 12.90%.

Analysts at Credit Suisse downgraded J. C. Penney Company (NYSE: JCP) from “neutral” to “underperform.” J. C. Penney's shares closed at $20.64 on Friday. J. C. Penney's trailing-twelve-month ROE is -8.73%.

Analysts at Goldman Sachs downgraded Garmin Ltd (NASDAQ: GRMN) from “neutral” to “sell.” Garmin's shares closed at $37.01 on Friday. Garmin's trailing-twelve-month ROA is 9.42%.

JP Morgan downgraded Caterpillar (NYSE: CAT) from “overweight” to “neutral.” Caterpillar's shares closed at $84.95 on Friday. Caterpillar's PEG ratio is 0.66.

Latest Ratings for JNJ

DateFirmActionFromTo
Aug 2016JefferiesMaintainsHold
Jul 2016Argus ResearchUpgradesHoldBuy
Jul 2016JefferiesMaintainsHold

View More Analyst Ratings for JNJ
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (GRMN + CAT)

View Comments and Join the Discussion!